Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Spier

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
Vaccine|January 1, 1995
Nucleic acid vaccines. 17-18 May 1994, WHO (OMS), Geneva, SwitzerlandR E Spier
Cytotechnology|January 1, 1993
A report on the meeting of the European Society for Animal Cell Technology (ESACT), held in Wurzburg, Germany on 17-21 May, 1993R E Spier
Vaccine|August 9, 2006
All change time for vaccine engineersR E Spier
Molecular Biotherapy|January 1, 1988
Continuous cell lines as substrates for biologicals: report of a joint meeting of WHO, IABS (cell Culture Committee Subsection), and ESACTR E Spier
Vaccine|April 1, 1991
International symposium on virological aspects of the safety of biological products. 8-9 November 1990, Zoological Society of London, under the auspices of Ares Serono Symposia and the International Association of Biological StandardisationR E Spier
Folia Microbiologica|January 1, 1997
Multivalent vaccines: prospects and challengesR E Spier
Vaccine|August 1, 1997
Introducing 'fence' vaccinesR E Spier
Vaccine|October 23, 1997
Infectious disease on the run. A report on the Children's Vaccine Initiative (CVI): consultative group meeting, Dakar, Senegal, 9-10 December 1996R E Spier
Developments in Biological Standardization|January 1, 1981
Animal cells or genetically engineered bacteria for the manufacture of particular bioproductsR E Spier
Vaccine|October 31, 1998
Ethical aspects of vaccines and vaccinationR E Spier
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
Vaccine|January 1, 1995
Nucleic acid vaccines. 17-18 May 1994, WHO (OMS), Geneva, SwitzerlandR E Spier
Cytotechnology|January 1, 1993
A report on the meeting of the European Society for Animal Cell Technology (ESACT), held in Wurzburg, Germany on 17-21 May, 1993R E Spier
Vaccine|August 9, 2006
All change time for vaccine engineersR E Spier
Molecular Biotherapy|January 1, 1988
Continuous cell lines as substrates for biologicals: report of a joint meeting of WHO, IABS (cell Culture Committee Subsection), and ESACTR E Spier
Vaccine|April 1, 1991
International symposium on virological aspects of the safety of biological products. 8-9 November 1990, Zoological Society of London, under the auspices of Ares Serono Symposia and the International Association of Biological StandardisationR E Spier
Folia Microbiologica|January 1, 1997
Multivalent vaccines: prospects and challengesR E Spier
Vaccine|August 1, 1997
Introducing 'fence' vaccinesR E Spier
Vaccine|October 23, 1997
Infectious disease on the run. A report on the Children's Vaccine Initiative (CVI): consultative group meeting, Dakar, Senegal, 9-10 December 1996R E Spier
Developments in Biological Standardization|January 1, 1981
Animal cells or genetically engineered bacteria for the manufacture of particular bioproductsR E Spier
Vaccine|October 31, 1998
Ethical aspects of vaccines and vaccinationR E Spier
Pageof 11